title: Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
abstract: Lethal graft-vs-host disease (GVHD) develops after transfer of CTL-depleted spleen and bone marrow cells from C57BL/6 (B6) mice to irradiated MHC class II disparate (B6xbm12)F1 recipients. Onset of lethal GVHD is significantly delayed in (bm1xbm12)F1 recipients of the same donor inoculum despite the additional MHC class I disparity (H-2Kbm1). To investigate the basis of this protective effect, hybridomas were generated from T cells activated in vivo during GVHD in both strain combinations. T cells from B6-->(B6xbm12)F1 mice generated a significantly higher frequency of B6.C-H-2bm12 (bm12)-specific T hybridomas (110/178, 62%) than T cells from B6-->(bm1xbm12)F1 mice (102/218, 47%). Some bm12-specific T hydridomas exhibited lesser responses to (bm1xbm12)F1 than to (B6xbm12)F1 APC. Moreover, bm1 peptides spanning a 14-amino acid region that includes the three amino acids that differ from H-2Kb were found to inhibit responses of some bm12-specific T hybridomas and to decrease significantly responses of splenic B6 CD4+ T cells to bm12 APC. Notably, the frequency of bm12-reactive hybridomas susceptible to inhibition by bm1 peptides generated from B6-->(B6xbm12)F1 mice was significantly greater than that generated from B6-->(bm1xbm12)F1 mice. Additional analysis using L cell transfectants indicated that hybridomas responding to the bm12 mutation at position 70 alone were rarely inhibited by bm1 peptides. The data indicate that expression of bm1-derived peptides can influence the frequency and specificity of alloreactive CD4+ T cells stimulated in vivo and thus may alter the course of GVHD.
authors.affiliation: Immunology Graduate Program, University of Texas Southwestern Medical Center at Dallas 75235, USA.
authors.forename: R R
authors.initials: RR
authors.lastname: Leibnitz
authors.forename: P E
authors.initials: PE
authors.lastname: Lipsky
authors.forename: D L
authors.initials: DL
authors.lastname: Thiele
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006183:H-2 Antigens / Q000502:physiology*; D000949:Histocompatibility Antigens Class II / Q000502:physiology*; D006825:Hybridomas / Q000276:immunology; D008213:Lymphocyte Activation; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000502:physiology*; D012680:Sensitivity and Specificity; D006377:T-Lymphocytes, Helper-Inducer / Q000502:physiology*; D014162:Transfection
chemical_list: D006183:H-2 Antigens; D000949:Histocompatibility Antigens Class II; D010446:Peptide Fragments